Clinical Study Of Heat-Sensitive Moxibustion To Reduce Bone Marrow Suppression In Patients After Tumor Chemotherapy

Research purpose: In this study,patients with tumor chemotherapy were treated with heat-sensitive moxibustion therapy to treat bone marrow suppression after chemotherapy in cancer patients.The clinical efficacy of heat-sensitive moxibustion to reduce bone marrow suppression response in patients with cancer after chemotherapy was discussed.The promotion and application provide a clinical basis.?Method: Forty-two patients with tumors who met the inclusion criteria(exploring bilateral Geshu and Shenshu with heat-sensitive moxibustion)were randomly divided into treatment group and control group,with 21 cases in each group.Both groups of patients were treated with conventional chemotherapy and conventional Western medicine for preventing chemotherapy and side effects.The treatment group selected bilateral Geshu and Shenshu points for heat-sensitive moxibustion on the basis of conventional treatment,starting from 3 days before chemotherapy.1 time,45 minutes each time,for 10 consecutive days for a course of treatment(including 4 days during chemotherapy),a total of 3 courses of treatment,each treatment interval of 1 day.The control group did not use heat-sensitive moxibustion.The patients were recorded before treatment,on the third day after chemotherapy,on the 14 th day after chemotherapy,on the 25 th day after chemotherapy,the white blood cell count,neutrophil count,hemoglobin count,blood cell count,general physical strength score,quality of life score,statistical analysis Differences between data before and after the group.Result: 1.Comparison of bone marrow suppression in the two groups after chemotherapy White blood cells and neutrophils: The white blood cell count and neutrophil count in the treatment group decreased on the third day after chemotherapy and on the 14 th day after chemotherapy,but the decrease was lighter than that in the control group.The white blood cell count of the treatment group was 25 days after chemotherapy.And neutrophil counts tend to restore pre-treatment levels,and there was no significant difference(P>0.05)compared with before treatment,compared with the control group(P<0.01),control group white blood cell count and neutrophil count The degree of decline was greater than that of the treatment group,and there was a recovery trend 25 days after chemotherapy but still lower than the pre-treatment level.Platelet: The platelet count in the treatment group decreased slightly on the third day after chemotherapy,and was at a lower level on the 14 th day after chemotherapy.The decrease was milder than that in the control group,but the difference was not statistically significant(P>0.05).On the 25 th day after chemotherapy,the platelet count of the treatment group showed a rising trend,higher than the pre-treatment level,and there was a significant difference(P<0.01)compared with the 14 th day after chemotherapy;the platelet count of the control group increased compared with the 14 th day after chemotherapy.However,the difference between the two was not statistically significant(P>0.05),and there was a significant difference(P<0.01)compared with before treatment.Hemoglobin: The hemoglobin count of the treatment group decreased slightly after chemotherapy,and there was no significant difference compared with the 14 th day after chemotherapy(P>0.05).There was no significant difference between the hemoglobin count of the control group and the 14 th day after chemotherapy(P> 0.05);There was no significant difference in the hemoglobin count between the treatment group and the control group(P>0.05).2.Comparison of general physical strength between the two groups before and after treatmentThere was no significant difference in the KPS score between the treatment group and the pre-treatment group(P>0.05).There was significant difference between the KPS score and the pre-treatment group(P<0.05).The KPS score of the treatment group was different from that of the control group.Statistically significant(P<0.05).3.Comparison of quality of life between the two groups before and after treatmentBefore treatment,the average quality of life scores of the two groups were in a good grade.After treatment,the quality of life score of the treatment group was higher than that before treatment,and there was significant difference between them(P<0.01).The quality of life score of the control group was lower than that before treatment.There was a significant difference(P<0.01).Conclusion: 1.Heat-sensitive moxibustion can alleviate the myelosuppressive response of cancer patients after chemotherapy;2.Heat-sensitive moxibustion can improve the quality of life of patients with cancer.